Fujii, K., Takahashi, H., Hayakawa, N., & Iwasaki, Y. (2021). Reply to Correspondence: Response to a case report: idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab. Respirol Case Rep.
Citação norma ChicagoFujii, Koki, Hidenori Takahashi, Nami Hayakawa, and Yoshinobu Iwasaki. "Reply to Correspondence: Response to a Case Report: Idiopathic Hypereosinophilic Syndrome in Remission With Benralizumab Treatment After Relapse With Mepolizumab." Respirol Case Rep 2021.
MLA CitationFujii, Koki, Hidenori Takahashi, Nami Hayakawa, and Yoshinobu Iwasaki. "Reply to Correspondence: Response to a Case Report: Idiopathic Hypereosinophilic Syndrome in Remission With Benralizumab Treatment After Relapse With Mepolizumab." Respirol Case Rep 2021.